Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PowerShares Dynamic Pharmaceuticals Portfolio (PJP)

During the Trading Day
75.02 +1.77 / +2.42%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
75.00 -0.02 / -0.03%
 
Volume: 110.00

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceuticals IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. It is non-diversified.

No recent news for PowerShares Dynamic Pharmaceuticals Portfolio.

Performance

1 month-10.28% 3 years+31.97%
3 months-6.10% 5 years+31.78%
1 year+19.28% Since inception+18.10%
Data through 09/02/2015

Quote Details

Previous close$73.25
Open day’s range73.43 – 75.02
Net asset value (NAV)73.22 (09/01/2015)
Daily volume231,385
Average volume (3 months)227,845
Data as of 3:59pm ET, 09/02/2015

Peer Comparisonvs. Health ETFs

 PJPCategory
Performance 5-yr return+31.78%+26.72%
Expense Gross exp ratio0.58%0.46%
Risk 5 year sharpe ratio2.351.76
Net assets$2.2B$2.2B
Average market cap$24.2B$38.7B
Average P/E25.326.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
DEPO Depomed Inc5.37%
AMGN Amgen5.36%
AGN Allergan5.12%
GILD Gilead Sciences4.98%
PFE Pfizer4.92%
BMY Bristol-Myers Squibb4.82%
NVAX Novavax Inc4.76%
JNJ Johnson & Johnson4.74%
MRK Merck4.59%
LGND Ligand Pharmaceuticals Inc4.37%

Partner Offers